• Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed Individuals who remain uninfected 

      Ruiz-Riol, M.; Llano, Anuska; Ibarrondo, Javier; Pérez Álvarez, Susana (2015-03-15)
      Article
      Accés obert
      The characterization of host immune responses to human immunodeficiency virus (HIV) in HIV controllers and individuals with high exposure but seronegativity to HIV (HESN) is needed to guide the development of effective ...
    • Definition of the viral targets of protective HIV-1-specific T cell responses 

      Pérez-Alvarez, Susana; Mothe, Beatriz; Llano, Anuska; Ibarrondo, Javier; Daniels, Marcus; Miranda, Cristina; Zamarreño, Jennifer; Bach, Vanessa; Zuniga, Rosario; Brander, C.; Sanchez, Jorge; Brumme, Chanson J.; Sánchez-Merino, Victor; Yang, Otto O.; Hildebrand, William H.; Szinger, James J.; Farfan, Marilu; Rolland, Morgane; Martínez-Picado, Javier; Puertas, Maria C.; Berger, Chistoph T.; Brumme, Zabrina L.; Korber, Bette T.; Gatell, Jose M.; Clotet, Bonaventura; Goulder, Philip J.; Walker, Bruce D.; Mullins, James I.; Gómez Melis, Guadalupe; Heckerman, David; Allen, Todd M. (2011-12-07)
      Article
      Accés obert
      Background: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction of responses with the most potent antiviral activity and broad HLA class I restriction. However, current HIV vaccine ...
    • HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: safety, immunogenicity and effect on the viral reservoir (Study BCN02) 

      Mothe, Beatriz; Rosas Umbert, Miriam; Coll, Pep; Manzardo, Christian; Puertas Castro, Maria C.; Morón López, Sara; Llano, Anuska; Alarcón Soto, Yovaninna; Gómez Melis, Guadalupe; Langohr, Klaus (2020-05-06)
      Article
      Accés obert
      Kick&kill strategies combining drugs aiming to reactivate the viral reservoir with therapeutic vaccines to induce effective cytotoxic immune responses hold potential to achieve a functional cure for HIV-1 infection. Here, ...